Summary
The EORTC Lymphoma Cooperative Group and the Pierre and Marie Curie Group conducted a multicentre randomised trial on clinical stages IIIB–IV Hodgkin’s disease from 1981–1986. Two hundred seven patients were registered and 192 randomised. Actuarial survival at five years for the whole group was 68%. Induction chemotherapy with eight cycles of MOPP resulted in more patients with progressive disease and fewer partial responders than a combination of MOPP and ABVD, for an equal complete remission rate. Half of the partial responders went into complete remission after radiotherapy. At five years there was no significant survival difference between the arms. Progression was recorded in 39 patients of whom only 4 survived. Relapses were most frequent in previously involved unirradiated areas. For 46 relapsed patients, including 21 early relapses within 18 months of start of treatment, the four-year survival rate was 53%. When complete remission was reached, whether early or late with combination chemotherapy or after additional radiotherapy, prognosis was independent of the way in which it was achieved. All efforts should be taken to reach a complete remission for initially progressing patients and for partial responders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Somers R, Henry-Amar M, Carde P, Najman A. On behalf of the EORTC Lymphoma Cooperative Group and the Group Pierre and Marie Curie: MOPP versus alternating 2 MOPP/2 ABVD in advanced Hodgkin’s disease. J Clin Onc 1988; 7: 236.
Wartelle M, Kromar A, Jam P, Kruger D. `PIGAS’: an interactive statistical data base management system. In: Hammond R and McCarthy JC (eds). Proceedings of the second international workshop in statistical data base management. Los Altos CA 1983; p 124–32.
Young RC, Canellos PG, Chabner BA et a1.Patterns of relapse in advanced Hodgkin’s disease treated with combination chemotherapy. Cancer 1978; 42: 1001–7.
Bloomfield CD, Pajak TF, Glicksman AS et al. Chemotherapy and Combined Modality Therapy for Hodgkin’s Disease: A Progress Report on Cancer and Leukemia Group B Studies; Cancer Treat Rep 1982; 66: 835–46.
Yahalom J, Gulati S, Shank B et al. Total Lymphoid irradiation, high dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin’s disease; Int J Rad Onc Biol Phys 1989; 17: 915–922.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Burgers, J.M.V. et al. (1991). Management of relapse and survival in advanced stage Hodgkin’s disease: The EORTC experience. In: Ultmann, J.E., Samuels, B.L. (eds) Annals of Oncology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7305-4_10
Download citation
DOI: https://doi.org/10.1007/978-1-4899-7305-4_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-7294-1
Online ISBN: 978-1-4899-7305-4
eBook Packages: Springer Book Archive